Arthritis Gout Taking Colchicine to Treat Gout Indications, Dosages, and Common Side Effects By Carol Eustice Carol Eustice Facebook Carol Eustice is a writer covering arthritis and chronic illness, who herself has been diagnosed with both rheumatoid arthritis and osteoarthritis. Learn about our editorial process Updated on October 10, 2022 Medically reviewed by David Ozeri, MD Medically reviewed by David Ozeri, MD LinkedIn David Ozeri, MD, is a board-certified rheumatologist from Tel Aviv, Israel specializing in arthritis, autoimmune diseases, and biologic therapies. Learn about our Medical Expert Board Print Table of Contents View All Table of Contents Indications Mechanism of Action Dosages Side Effects Considerations and Contraindications Colchicine is a prescription medication available under the brand name Colcrys or in generic form. Colchicine is a preferred treatment for gouty arthritis and is derived from the dried seeds of Colchicum autumnale (also known as the autumn crocus or meadow saffron) . Jan-Otto/E+/Getty Images Indications for Using Colchicine The use of C. autumnale alkaloids for the treatment of gout dates back to 1810. The medicinal value of colchicum was reported back in the first century A.D. Colchicine can be used to manage conditions other than gout, including: Amyloidosis Behcet's disease Dermatitis herpetiformis Familial Mediterranean fever Paget's disease Pericarditis Pseudogout Mechanism of Action While colchicine has potent anti-inflammatory properties, its efficacy in treating pain other than gout is limited. Colchicine is not considered analgesic (pain-relieving) and does nothing to alter high uric acid levels associated with gout. Colchicine works by binding to a type of white blood cell called a neutrophil. By doing so, the cells are unable to migrate to areas where uric acid crystals have accumulated. This tempers the inflammatory response and, with it, much of the pain. Colchicine also has a suppressive effect that helps to decrease acute gout attacks, thereby relieving pain and discomfort associated with gout. Dosages Colchicine is only started in someone gout patients when they have two or more attacks per year. The starting dose is two tabs of 0.6 mg colchicine tabs daily; this continues while titrating uric acid-lowering therapy with Uloric or allopurinol. Colchicine with uric acid-lowering therapy is continued until uric acid is below 6.0. For acute flares coclchine may be increased to three tablets a day for a few days; if there is GI discomfort, the daily dose may be decreased to one tab daily. The drug should be stopped if there is gastrointestinal discomfort or diarrhea. Gout Prevention Colchicine is also recommended for regular use between attacks for prophylactic (preventive) therapy. In people who have less than one gout attack per year, the usual dose is 0.5 or 0.6 mg per day, three or four days a week. For those who have more than one attack per year, the usual dose is 0.5 or 0.6 mg daily. Severe cases may require two or three 0.5 mg or 0.6 mg tablets daily. While colchicine is reserved for use in adults with acute gout flares, it can be used prophylactically in adolescents 16 and over. Its only approved use in children is for the treatment of familial Mediterranean fever (FMF). Side Effects Adverse reactions can occur with colchicine use and it's important for you to be aware of that potential. Bone marrow depression, with aplastic anemia, with agranulocytosis, or with thrombocytopenia may occur in people receiving long-term therapy. Other possible adverse reactions include: Peripheral neuritisPurpuraMyopathyHair lossReversible azoospermia (complete absence of sperm) Vomiting, diarrhea, and nausea are side effects that may occur with colchicine therapy, especially when the maximum doses are prescribed. To decrease side effects, colchicine may be taken with food. Considerations and Contraindications for Taking Colchicine Pregnant women must weigh the risks and benefits of colchicine use. Colchicine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Colchicine can arrest cell division, so it may be a significant risk to take the drug while pregnant. Caution should also be exercised when colchicine is administered to a woman who is nursing. Gout Doctor Discussion Guide Get our printable guide for your next doctor's appointment to help you ask the right questions. Download PDF Sign up for our Health Tip of the Day newsletter, and receive daily tips that will help you live your healthiest life. Sign Up You're in! Thank you, {{form.email}}, for signing up. There was an error. Please try again. Colchicine should also not be used by a person with a known hypersensitivity to the drug, or by anyone with a serious gastrointestinal, renal, hepatic, or cardiac disorder. Also, people with blood disorders should not use colchicine. Treating Gout 13 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Colchicine. Unverdi S, Inal S, Ceri M, et al. Is colchicine therapy effective in all patients with secondary amyloidosis?. Ren Fail. 2013;35(8):1071-4. doi:10.3109/0886022X.2013.811345 Nair JR, Moots RJ. Behcet's disease. Clin Med (Lond). 2017;17(1):71-77. doi:10.7861/clinmedicine.17-1-71 Silvers DN, Juhlin EA, Berczeller PH, Mcsorley J. Treatment of dermatitis herpetiformis with colchicine. Arch Dermatol. Sönmez HE, Batu ED, Özen S. Familial Mediterranean fever: current perspectives. J Inflamm Res. 2016;9:13-20. doi:10.2147/JIR.S91352 Theodors A, Askari AD, Wieland RG. Colchicine in the treatment of Paget disease of bone: a new therapeutic approach. Clin Ther. Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A. Colchicine for pericarditis. Cochrane Database Syst Rev. 2014;(8):CD010652. doi:10.1002/14651858.CD010652.pub2. Macmullan P, Mccarthy G. Treatment and management of pseudogout: insights for the clinician. Ther Adv Musculoskelet Dis. 2012;4(2):121-31. doi:10.1177/1759720X11432559 Engel B, Just J, Bleckwenn M, Weckbecker K. Treatment Options for Gout. Dtsch Arztebl Int. 2017;114(13):215-222. doi:10.3238/arztebl.2017.0215 Sadiq NM, Robinson KJ, Terrell JM. Colchicine. In: StatPearls. Treasure Island (FL): StatPearls Publishing. Altiparmak MR, Pamuk ON, Pamuk GE, Hamuryudan V, Ataman R, Serdengecti K. Colchicine neuromyopathy: a report of six cases. Clin Exp Rheumatol. Ding J, Shang X, Zhang Z, et al. FDA-approved medications that impair human spermatogenesis. Oncotarget. 2017;8(6):10714-10725. doi:10.18632/oncotarget.12956 Indraratna PL, Virk S, Gurram D, Day RO. Use of colchicine in pregnancy: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(2):382-387. doi:10.1093/rheumatology/kex353 Additional Reading Colchicine. RxList. The Internet Drug Index. Colcrys. Colchicine. MedlinePlus. Kelley's Textbook of Rheumatology. Elsevier. Ninth edition. Chapter 95: Clinical Features and Treatment of Gout - Colchicine. By Carol Eustice Carol Eustice is a writer covering arthritis and chronic illness, who herself has been diagnosed with both rheumatoid arthritis and osteoarthritis. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit